Form D · Other Technology
KYTO BIOPHARMA INC
Los Altos Hills, CA · CIK 0001164888
Offering snapshot reported May 9, 2018 · SEC filing
- Reported sold
- $845K Offering amount: $1.2M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Apr 24, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 9, 2018 | Initial | $845,000 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-312033
Right to Acquire Security
Source: Form D, filed May 9, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Georges Benarroch | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
13050 La Palma Road
Los Altos Hills, CA, 94022
Los Altos Hills, CA, 94022